bpc-157 clinicaltrials.gov BPC-157: Miracle Healing Peptide or Hidden Danger? Home

It is created using solid phase peptide synthesis, which adds an additional tyrosine to the N-terminal

A.et al (2018)

If you have infectious bursitis, you may notice fever or chills accompanying joint pain

Berlin H, Berlin R, Brante G (1968) ORAL Treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor

Key characteristics: 28 to 90 day beyond-use date from preparation (varies by pharmacy) May or may not contain preservatives Multi-dose vials requiring multiple punctures Potency can vary between batches Different pharmacies produce different quality levels Storage requirements may differ from brand-name The variability between compounding pharmacies is significant

Ask about manufacturing, storage, and shipping conditions